Introduction {#sec1-1}
============

Non-communicable diseases (NCDs) kill 41 million people each year, equivalent to 71% of all deaths globally.\[[@ref1]\] According to the ICMR India State-Level Disease Burden Study report "India: Health of the Nation's States," the estimated proportion of all deaths due to NCDs has increased from 37.09% in 1990 to 61.8% in 2016.\[[@ref2]\] The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. The global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.55% in 2014. Almost half of all deaths were attributable to high blood glucose and occurred before the age of 70 years.\[[@ref3]\] Physical inactivity, faulty diet, sedentary lifestyle habits and stress are the major risk factors of noninsulin-dependent diabetes. The main aim of the management of diabetes is to lower the blood glucose level either by intervention of medicine or by improving behavior of diet and lifestyle.

Ayurveda emphasized on the management of *Prameha* through diet and lifestyle modification (which can be correlated to diabetes).\[[@ref4]\] Studies have also shown the effectiveness of Ayurveda intervention in the management of type 2 diabetes.\[[@ref5]\]

Global report on diabetes (2016) by the WHO\[[@ref6]\] and the National Health Policy (2017)\[[@ref7]\] emphasized on the integrated management of NCDs. Keeping in view the strength of AYUSH systems for the prevention and management of NCDs by promoting healthy lifestyle, a project aimed for "Integration of AYUSH (Ayurveda) with National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS)" was conceived in 2015 by the Ministry of AYUSH and Central Council for Research in Ayurvedic Sciences (CCRAS) in collaboration with Directorate General of Health Services, Ministry of Health and Family Welfare (MoHFW), for imparting health services on pilot basis in the three districts of three states, namely Bhilwara (Rajasthan), Gaya (Bihar) and Surendranagar (Gujarat).\[[@ref8]\] The present article reports interim analysis of the patient outcome through integrated management of diabetes (from April 2016 to December 2017) at 17 community health centers (CHCs) and 1 district hospital (DH) of Gaya district.

Objectives {#sec2-1}
----------

The objective of this study was to analyze the effect of Ayurveda intervention, lifestyle modification and Yoga in the management of type 2 diabetes under NPCDCS-AYUSH integration project.

Materials and Methods {#sec1-2}
=====================

A multicenter, open-labeled study was conducted at 17 CHCs and 1 DH in Gaya district of Bihar. A total number of 1,04,627 individuals were screened for type 2 diabetes at 17 CHCs and 1 DH between April 2016 and December 2017 and out of them, a total of 7735 participants were enrolled as prediabetic and type 2 diabetic patients for integrated management between April 2016 and December 2017. The data of all those patients who completed the management of 6 months, i.e. 3044 patients were included in the analysis. Dropped out cases were 2049 and the rest of 2642 patients were at different phases of management as it is a ongoing project.

Enrolled patients were distributed in two cohorts: pre-diabetic, i.e., Cohort A and type 2 diabetic, i.e. Cohort B. Each cohort was further divided into two groups, i.e. A1 and A2 and B1 and B2 as follows:

Group A1 was advised for lifestyle modification and *Yoga*Group A2 was given Ayurveda medication, lifestyle modification and *Yoga*Group B1 was advised for lifestyle modification and *Yoga* along with allopathic medicationGroup B2 was given Ayurveda medication, lifestyle modification and *Yoga* along with allopathic medication.

Ethical clearance {#sec2-2}
-----------------

The study protocol was approved by the Institutional Ethical Committee (15-1/IMR/RARIID/Patna/17-18/835 dated on June 10, 2017) and written informed consent was also taken before enrollment for intervention.

The case record forms (CRFs) and electronic format (E-format) were designed for recording the data of registered patients. The schematic diagram of the project is depicted in [Figure 1](#F1){ref-type="fig"}.

![Scheme of categorization of patients](AYU-40-8-g001){#F1}

Diagnostic criteria {#sec2-3}
-------------------

Cohort A: The Indian Diabetic Risk Score (IDRS)\[[@ref9]\] 30--60 and adults with impaired fasting glucose as per the American Diabetes Association (ADA)\[[@ref10]\] criteria (fasting plasma glucose \[FPG\] level between 100 and 125 mg/dL).Cohort B: IDRS \>60, adults with FPG ≥126 mg/dl (7.0 mmol/l), or patients with classical symptoms of hyperglycemia or hyperglycemic crisis having random plasma glucose ≥200 mg/dl (11.1 mmol/l) as per the ADA\[[@ref10]\] criteria and patients of type 2 diabetes with or without complications on standard care of treatment.

Inclusion criteria {#sec2-4}
------------------

Cohorts A and B: Patients of either sex aged between 30 and 60 years and those who are willing to give written informed consent were included.

Exclusion criteria {#sec2-5}
------------------

Cohorts A and B: Known cases of HIV positive; type 1 diabetic individuals; patients having a history of cardiovascular diseases such as bundle branch block, transient ischemic attack, uncontrolled hypertension and stroke; patients who have undergone recent or significant abdominal surgery (e.g., gastrectomy) during the past 6 months; patients on corticosteroids and hormonal treatment; pregnant and lactating mothers and patients having any major systemic illness were excluded.

The registered patients were provided the treatment as per their study cohort for 6 months as shown in [Figure 2](#F2){ref-type="fig"}. The laboratory investigations such as fasting blood sugar (FBS), postprandial blood sugar (PPBS) and hemoglobin A~1~C (HbA~1~C) were conducted (as per the availability of investigations facilities with state health authorities) at baseline and at the end of 6^th^ month.

![Methodology for enrollment of patients](AYU-40-8-g002){#F2}

Withdrawal criteria {#sec2-6}
-------------------

Patients with irregularity in follow-up or missing consecutive three follow-upsNoncompliance of treatment protocolDeveloped any serious side effect.

Pharmacological interventions {#sec2-7}
-----------------------------

Keeping in view of classical texts and various research studies, the *Mamajjaka* capsule (powdered dried whole plant of *Enicostemma* *littorale* Blume) 1 g, *Amalaki* *Churna* (powdered dried fruit of *Emblica* *officinalis* Gaertn.) 3 g and *Guduchi* *Churna* (powdered dried stem of *Tinospora* *cordifolia* (Willd.) Miers.) 3 g twice a day after meals with lukewarm water were administered for the management of type 2 diabetes. The medicines were procured from Good Manufacturing Practices (GMP) certified Ayurvedic pharmaceutical companies as per pharmacopoeial standards. The medicines were prescribed for 6 months.

The list of common allopathic medications prescribed by the allopathic physicians for type 2 diabetic patients in the study contains chlorpropamide, tolbutamide, glibenclamide, glibornuride, tolazamide, glipizide, gliclazide and metformin.

Diet and lifestyle modification {#sec2-8}
-------------------------------

The details of the advocacy on diet and lifestyles on diabetes are shown in [Table 1](#T1){ref-type="table"}.

###### 

Details of advocacy on diet and lifestyles for pre-diabetic and type 2 diabetes patients

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Do's                                                                                                                                                                                                                           Dont's
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------
  Intake of old harvested cereals, barley (*Yava*), sorghum (*Jwar*), whole\                                                                                                                                                     Sugarcane juice, jaggery, sugar, milk products\
  wheat atta, bitter gourd (*Karela*), green leafy vegetables, garlic (*Rasona*), turmeric (*Haridra*), *Aloe vera* (*Kumari*) in vegetables (leafy) and fruits such as guava, oranges and Indian blackberry (*Jammbu Phala*)\   Reduce intake of rice, food rich in carbohydrate and fried, or processed food\
  Timely intake of diet\                                                                                                                                                                                                         Sedentary lifestyle\
  Regular exercise, especially walking\                                                                                                                                                                                          Sleeping in the daytime and excessive sleeping\
  Regular practice of *Yoga*, meditation, etc., under the supervision of *Yoga* specialist is suggested                                                                                                                          Alcohol consumption\
                                                                                                                                                                                                                                 Staying too long on empty stomach\
                                                                                                                                                                                                                                 Cold drinks, ice cream, burger-pizza and other fast foods.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Yogasana intervention for prediabetic and type 2 diabetes {#sec3-1}

A list of selected *Asana*/*Kriya/Pranayama* was advocated under the supervision of *Yoga* experts for practice by enrolled patients depending on the age and severity of disease, as mentioned in [Table 2](#T2){ref-type="table"}.

###### 

Details of *Asana/Kriya/Pranayama* advocated

  -----------------------------------------------------------------------------------------
  *Yogasana*                                             *Pranayama*      *Kriya*
  ------------------------------------------------------ ---------------- -----------------
  *Surya Namaskar, Tadasana*,\                           *Nadi*\          *Kunjal*,\
  *, Sarvangasana*,\                                     *Shodhana*,\     *Kapalabhati*,\
  *Halasana, Matsyasana, Ushtrasana*,\                   *Suryabhedi*,\   *Agnisara*
  *Gomukhasana, Ardha*\                                  *Bhastrika*      
  *Matsyendrasana, Mandukasana*,\                                         
  *Paschimottanasana, Pawanmuktaasana, Bhujangasana*,\                    
  *Shalabhasana, Dhanurasana*,\                                           
  *Vajrasana, Shavasana*                                                  

  -----------------------------------------------------------------------------------------

Assessment criteria {#sec2-9}
-------------------

Blood sugar level: As per ADA, the fasting and PPBS levels were measured at baseline and the 6^th^ monthSubjective symptoms of type 2 diabetes such as polyuria, polydipsia, polyphagia, weakness, non-healing ulcer and blurred vision of the individual patients were measured on following scoring:Absent: 0 Mild: 1 Moderate: 2 Severe: 3Changes in subjective symptoms after treatment:Static: No change in subjective symptoms at 6^th^ month from baselineImproved: Improvement in subjective symptoms at 6^th^ month from baselineWorse: Increase in severity of subjective symptoms at 6^th^ month from baseline.

Statistical analysis {#sec2-10}
--------------------

The demographic variables and chief complaints have been presented in percentage. The continuous data for blood glucose level within the group related to outcome variables were subjected to paired *t*-test. *P* \<0.05 has been considered as statistically significant.

Results and Observations {#sec1-3}
========================

Study cohort {#sec2-11}
------------

A total of 7735 participants (56 in group A1, 1565 in group A2, 43 in group B1 and 6071 in group B2) were enrolled as prediabetic and type 2 diabetic patients for the integrated management during April 2016 to December 2017. The data of patients who had completed the management of 6 months, i.e., 3044 patients (15 in group A1, 487 in group A2, 13 in group B1 and 2529 in group B2) were included in the analysis. Dropped out cases were 2049 (13 in group A1, 546 in group A2, 7 in group B1 and 1483 in group B2) and the rest of 2642 patients (28 in group A1, 532 in group A2, 23 in group B1 and 2058 in group B2) were at different phases of management as it is a continuous running project. [Figure 3](#F3){ref-type="fig"} shows the outflow of patients in the study from April 2016 to December 31, 2017.

![Outflow of the patients in the study](AYU-40-8-g003){#F3}

The study revealed that maximum patients (68.4%) were male in gender and the mean age of all the patients was between 45 and 54 years. About 25.4% of patients were illiterate, followed by 19.6% of patients who were educated above senior secondary. Almost 32.2% were homemakers. The baseline demographic data of the patients are summarized in [Table 3](#T3){ref-type="table"}.

###### 

Baseline characteristics of the study participants (*n*=3044) (Demographics)

  Variables                 *n* (%)
  ------------------------- ---------
  Mean age (year)           45-54
  Gender                    
   Male                     64.8
   Female                   35.2
  Education                 
   Illiterate               25.4
   Up to primary            14.7
   Up to middle             21.7
   Up to senior secondary   18.5
   College and above        19.6
  Occupation                
   Desk work                14.7
   Field work               28.6
   Homemaker                32.2
   Others                   24.5

### Effect of management of type 2 diabetes on subjective symptoms {#sec3-2}

Changes in subjective symptoms after treatment were assessed with following criteria:

Static: No change in subjective symptoms at 6^th^ month from baselineImproved: Improvement in subjective symptoms at 6^th^ month from baselineWorse: Increase in severity of subjective symptoms at 6^th^ month from baseline.

The effect of management of type 2 diabetes on subjective symptoms is depicted in Graphs [1](#F4){ref-type="fig"}--[6](#F9){ref-type="fig"} and [Table 4](#T4){ref-type="table"}.

![The effect of intervention on the symptom of polyuria, *n*=3044](AYU-40-8-g004){#F4}

![The effect of intervention on the symptom of polydipsia, *n*=3044](AYU-40-8-g005){#F5}

![The effect of intervention on the symptom of polyphagia, *n*=3044](AYU-40-8-g006){#F6}

![The effect of intervention on the symptom of weakness](AYU-40-8-g007){#F7}

![The effect of intervention on the symptom of blurred vision](AYU-40-8-g008){#F8}

![The effect of intervention on the symptom of non-healing ulcer](AYU-40-8-g009){#F9}

###### 

The effect of management of type 2 diabetes on subjective symptoms and signs

  Complaint                   Group   Static (%)   Improved (%)   Worsened (%)
  --------------------------- ------- ------------ -------------- --------------
  Polyuria                    A1      33.3         60.0           6.7
  A2                          24.9    73.6         1.4            
  B1                          23.1    77.0         0.0            
  B2                          19.4    79.6         0.8            
  Polydipsia                  A1      40.0         60.0           0.0
  A2                          23.3    76.0         0.8            
  B1                          15.4    84.7         0.0            
  B2                          20.7    78.4         0.9            
  Polyphagia                  A1      46.7         46.7           6.6
  A2                          38.8    59.4         1.8            
  B1                          53.9    46.2         0.0            
  B2                          34.0    64.8         1.1            
  Weakness                    A1      26.6         73.3           0.0
  A2                          29.1    68.4         2.4            
  B1                          15.4    84.7         0.0            
  B2                          22.2    75.4         1.7            
  Blurred vision              A1      46.7         46.7           6.6
  A2                          64.1    33.5         2.5            
  B1                          53.9    46.2         0.0            
  B2                          57.6    39.5         2.8            
  Nonhealing ulcer (if any)   A1      100.0        \-             \-
  A2                          96.9    2.3          0.8            
  B1                          100.0   \-                          
  B2                          95.8    3.2          1.0            

Grading of the symptoms of type 2 diabetes, i.e., polyuria, polydipsia, polyphagia, weakness, blurred vision and non-healing ulcer was done at baseline and the 6^th^ month and recorded in CRFs.

### Effect of integrative management {#sec3-3}

The effect of integrative management in blood sugar level is shown in [Table 5](#T5){ref-type="table"} and Graphs [7](#F10){ref-type="fig"}, [8](#F11){ref-type="fig"}. A significant reduction in the FBS level was observed from baseline to 6 months after intervention of integrative management in groups A2, B1 and B2, whereas non-significant reduction in the FBS level was observed in group A1. It was also observed that there was a significant reduction in the PPBS level from baseline to 6 months in groups A2, B1 and B2, whereas non-significant reduction in the FBS level was observed in group A1.

###### 

Effect on fasting blood sugar and postprandial blood sugar

  Parameters                         Groups     0 day (BT)-after 6 months (AT)   Paired differences   *t*      *P*                                   
  ---------------------------------- ---------- -------------------------------- -------------------- -------- -------- --------- -------- --------- -------
  Blood sugar fasting (mg/dl)        Group A1   BT                               120.32               6.117    2.735    −11.435   39.675   1.534     0.200
  AT                                 106.20     21.534                           9.630                                                               
  Group A2                           BT         108.85                           10.894               1.168    8.076    14.990    6.663    \<0.001   
  AT                                 97.32      12.402                           1.330                                                               
  Group B1                           BT         128.80                           28.940               9.152    2.915    34.685    2.677    0.025     
  AT                                 110.00     13.367                           4.227                                                               
  Group B2                           BT         163.59                           56.190               1.620    48.692   54.758    33.456   \<0.001   
  AT                                 111.87     24.098                           0.695                                                               
  Blood sugar postprandial (mg/dl)   Group A1   BT                               168.85               43.091   17.592   −47.952   54.985   0.176     0.867
  AT                                 165.33     33.720                           13.766                                                              
  Group A2                           BT         169.13                           21.598               1.619    19.918   28.974    10.653   \<0.001   
  AT                                 144.68     24.345                           1.8525                                                              
  Group B1                           BT         205.00                           42.834               14.278   12.494   64.617    3.412    0.009     
  AT                                 166.44     33.313                           11.104                                                              
  Group B2                           BT         244.39                           76.309               2.036    83.097   91.084    42.780   \<0.001   
  AT                                 157.30     35.789                           0.955                                                               

CI: Confidence interval, SD: Standard deviation, SEM: Standard error of mean, AT: After Treatment, BT: Before Treatment, *n*=3044

![The effect of integrative management on fasting blood sugar level](AYU-40-8-g010){#F10}

![The effect of integrative management on postprandial blood sugar level](AYU-40-8-g011){#F11}

Discussion {#sec1-4}
==========

The trial drugs, i.e., *Mamajjaka*, *Amalaki* and *Guduchi* were found effective in controlling FBS and PPBS levels in type 2 diabetic individuals. *Mamajjaka* is a folklore drug which has been practiced since long time for the management of *Prameha* in India. Various studies have documented the potential role of *Mamajjaka* in controlling blood sugar levels.\[[@ref11]\] It possesses *Bitter Taste (Tikta Rasa)*\[[@ref12]\] which is known to help in stimulating metabolism.

*Amalaki* and *Guduchi* are documented in the Ayurvedic Pharmacopoeia of India to possess anti-diabetic activity.\[[@ref13][@ref14]\] Further, *Amalaki* and *Guduchi* impart rejuvenating (*Rasayana*) effect that causes improvement in digestive functions and metabolism, thus enhancing glucose uptake by the cells. *Amalaki* is a rich source of Vitamin C and amino acids\[[@ref15]\] and possesses immune-modulatory effect\[[@ref16]\] and antioxidant activity.\[[@ref17]\] Studies reported that *Guduchi* enhances glucose tolerance and lowers the blood glucose level.\[[@ref18]\] It possesses antioxidant activity.\[[@ref19]\]

Lifestyle modification contributes to the effect of Ayurveda medications as proper diet, abstinence of substance abuses such as tobacco and alcohol and management of daily routines will remove the causative factors of disease and help in preventing progression of disease.

*Yoga* has been practiced since ancient times to manage the physiology of the body. This not only improves the flexibility but also improves the function of both endocrines and exocrine glands of the body. Various studies have reported that *Yoga* has a positive impact in the management of type 2 diabetes. Different *Asanas* such as *Surya Namaskara* and *Tadasana* help in insulin production and improve digestive fire. Cleansing process in *Yoga* *Kriya* like *Kapalnbhati* and *Agnisara* stimulates pancreatic cells and improves their efficiency.\[[@ref20]\]

Subjective symptoms of type 2 diabetes, i.e. polyuria, polydipsia, polyphagia, blurred vision, and weakness showed improvement in all the groups. This was possibly due to elimination of causative factors through lifestyle modification and improvement in physiology through *Yogic* practices. Further, pharmacological intervention controls the blood sugar levels and thus, relief in subjective symptoms was observed. Few patients felt improvement in vision which may be due to retinopathy changes which are nonreversible. Fewer people perceived an improvement in non-healing ulcer. This is possibly because of requirement of localized treatment of the ulcer tissue.

On comparing the *P* values of the four groups in FBS, it was observed that though lifestyle and *Yoga* have a positive impact over the disease management, the groups having medical intervention in the form of Ayurveda or allopathic medicine, i.e. groups A2, B1 and B2 performed better than group A1. This implies that lifestyle and *Yoga* can prevent disease progression through removal of causative and aggravating factors, but pharmacological intervention is required to manage the disease. *Yoga* regulates eating pattern and leads to medication adherence.\[[@ref20]\] Diet plays an important role in the management of every disease as medicine is effective only in the presence of proper diet.\[[@ref21]\]

Similarly, groups having Ayurveda medication, i.e., groups A2 and B2 showed better treatment outcome than group B1 which is having allopathic medicine along with lifestyle and *Yoga* in diseased cases. This signifies that type 2 diabetic patients responded better to Ayurveda medications, i.e., *Mamajjaka*, *Amalaki* and *Guduchi* in the current study. The reasons for better response may be multi-modal action of Ayurveda medications which not only relieve the symptoms but also stimulate the glands, rejuvenate the cells, and improve the uptake of glucose in the body and may probably increase insulin sensitivity. Similar observations were also observed during analysis of PPBS levels.

This highlights the importance of management of type 2 diabetes through integrative approach with Ayurveda medications that help to correct the vitiated *Dosha* and help in improving metabolism as reflected through the laboratory parameters and subjective parameters. Thus, Ayurveda intervention exhibits potential for integrative management along with lifestyle modifications, *Yoga* and allopathic anti-diabetic agents.

The acceptance of Ayurveda intervention was overwhelming among population as depicted by large proportion of participants in groups A2 and B2, where Ayurveda medication was prescribed. Further, a number of participants in the groups without Ayurveda medications were very less. The reason may be the inclination of individuals for pharmacological treatment of type 2 diabetes mellitus.

Limitations of the study {#sec2-12}
------------------------

The laboratory investigations such as serum insulin HbA~1~C, fasting and PPBS are the key factors in diagnosis and analysis of the result of the study, but there was restricted availability of in-house and outsourced laboratory facilities at every CHCs well in time.

Conclusion {#sec1-5}
==========

The study reveals that Ayurveda intervention, i.e. *Mamajjaka* *Churna* (1 g), *Amalaki* *Churna* (3 g) and *Guduchi* *Churna* (3 g) two times/day effectively controls blood sugar level in pre-diabetic and type 2 diabetic patients and improves the disease management with lifestyle modification and *Yogasana* as well as with allopathic treatment.

Way forward {#sec2-13}
-----------

Further studies should be carried out for the assessment of quality of life during integrative managementThe present study shows an increased flow of participants in groups having medical intervention. This implies a psychological aspect of taking some medication along with lifestyle modification and *Yoga* for the treatment of type 2 diabetes. Hence, to get comparable number of participants in each group, further studies may be planned with a placebo in those groups where only lifestyle modification and Yoga had been prescribed.
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